Medihoney™, Derma Sciences Inc’s (Princeton, NJ) Wound & Burn Dressing with Active Leptospermum Honey, was recently found to significantly improve the healing rates of stalled venous leg ulcers in a large randomized, controlled clinical trial. Prior to this study, no other advanced wound care dressing under compression therapy demonstrated improved healing rates of leg ulcers.

In the 108-patient randomized, controlled clinical trial, venous leg ulcers that had been proven to be nonhealing under standard treatment (compression therapy) were examined. Half of the patients had a common advanced wound care gel added to the standard treatment, while the other half of the patients had Active Leptospermum (Manuka Honey) added. After 4 weeks, the mean reduction in size of the wounds was 34% in the honey group and 13% in the control group. After 12 weeks, there was a 44% complete healing rate in the honey group compared to only 33% in the control group.

Physicians treat more than 4 million leg ulcers in the United States annually, with a total cost exceeding $1 billion. Since the launch of Medihoney in Europe a few years ago, and most recently in the United States and Canada, clinicians have consistently reported that Medihoney is considerably effective on stalled ulcers of various etiologies.

Visit http://www.dermasciences.com for more information.